Medication safety information changes. This page summarizes FDA’s ranitidine removal notice and does not provide medical advice or determine whether a product caused a health condition.

FDA’s 2020 request

In April 2020, the FDA requested the removal of all prescription and over-the-counter ranitidine products from the U.S. market. FDA explained that NDMA levels could increase over time and with storage at higher-than-room temperatures. The notice is not a clinical diagnosis and does not identify what a particular person’s medical records establish.

Use current medical and product information

For a question about a current medication, speak with an appropriate health professional or pharmacist and consult current FDA information. Do not stop, start, or substitute medication based solely on a historical web article.

Keep original information if it is relevant

  • Medication name, packaging, lot information, dates, and pharmacy or purchase records
  • Medical records and instructions kept in their original form
  • FDA notices and communications relevant to the product
  • A clear distinction between a product notice and an individual medical or legal conclusion

Questions about a possible North Carolina personal-injury matter depend on the evidence, applicable law, and individual circumstances.

Source